{"id":390838,"date":"2020-12-01T10:03:21","date_gmt":"2020-12-01T15:03:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=390838"},"modified":"2020-12-01T10:03:21","modified_gmt":"2020-12-01T15:03:21","slug":"fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/","title":{"rendered":"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n

\n NEW YORK<\/span>, Dec. 1, 2020<\/span> \/PRNewswire\/ — Attorney Advertising —\u00a0Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fortress Biotech, Inc.\u00a0(“Fortress Biotech” or “the Company”) (NASDAQ: FBIO)\u00a0and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fortress Biotech\u00a0securities between\u00a0December 11, 2019 and October 9, 2020<\/span> both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com\/fbio<\/a>. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n

\n

\n
\n \"Bronstein,
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0<\/p>\n

The Complaint alleges that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (1) IV Tramadol was not safe for the intended patient population; (2) as a result, it was foreseeable that the FDA would not approve the NDA for IV Tramadol; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times. <\/p>\n

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com\/fbio<\/a> or you may contact Peretz Bronstein, Esq.<\/span> or his Investor Relations Analyst, Yael Hurwitz<\/span> of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Fortress Biotech you have until January 26, 2021<\/span> to request that the Court appoint you as lead plaintiff.\u00a0 Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.<\/p>\n

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.\u00a0 Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.\u00a0 In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.\u00a0 \u00a0Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein<\/span> or Yael Hurwitz<\/span>
212-697-6484 | info@bgandg.com<\/a><\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/fbio-shareholder-alert-bronstein-gewirtz–grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021-301181299.html<\/a><\/p>\n

SOURCE Bronstein, Gewirtz & Grossman, LLC<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK, Dec. 1, 2020 \/PRNewswire\/ — Attorney Advertising —\u00a0Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fortress Biotech, Inc.\u00a0(“Fortress Biotech” or “the Company”) (NASDAQ: FBIO)\u00a0and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fortress Biotech\u00a0securities between\u00a0December 11, 2019 and October 9, 2020 both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com\/fbio. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0 The Complaint alleges that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to … <\/p>\n

Continue reading “FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-390838","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Dec. 1, 2020 \/PRNewswire\/ — Attorney Advertising —\u00a0Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fortress Biotech, Inc.\u00a0(“Fortress Biotech” or “the Company”) (NASDAQ: FBIO)\u00a0and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fortress Biotech\u00a0securities between\u00a0December 11, 2019 and October 9, 2020 both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com\/fbio. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0 The Complaint alleges that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to … Continue reading "FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-01T15:03:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021\",\"datePublished\":\"2020-12-01T15:03:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/\"},\"wordCount\":377,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/\",\"name\":\"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\",\"datePublished\":\"2020-12-01T15:03:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/","og_locale":"en_US","og_type":"article","og_title":"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk","og_description":"PR Newswire NEW YORK, Dec. 1, 2020 \/PRNewswire\/ — Attorney Advertising —\u00a0Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fortress Biotech, Inc.\u00a0(“Fortress Biotech” or “the Company”) (NASDAQ: FBIO)\u00a0and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fortress Biotech\u00a0securities between\u00a0December 11, 2019 and October 9, 2020 both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com\/fbio. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0 The Complaint alleges that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to … Continue reading \"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-01T15:03:21+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021","datePublished":"2020-12-01T15:03:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/"},"wordCount":377,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/","name":"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","datePublished":"2020-12-01T15:03:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/390838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=390838"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/390838\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=390838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=390838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=390838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}